AVTX Avalo Therapeutics, Inc.
$16.12▼ -6.17%
Healthcare
Other
After hours
$16.12▲ +0.00%
Sep 11, 7:30 PM ET
Volume 2.53M
Avg Volume (10D) 785.6K
Key Metrics & Fundamentals
Market Cap
$864.52M
P/E Ratio
–
Div Yield
–%
52W Range
9.54 - 24.27
% vs 50 MA
-15.44%
% vs 200 MA
-4.72%
RSI-14
32.4
MACD Histogram
-0.3900
Beta (1Y vs SPY)
1.24
Free Cash Flow
-$19.99M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$23.92M
COGS
–
Operating Exp
$31.52M
Operating Income
-$31.52M
EBIT
-$31.52M
Pretax Income
-$36.34M
Net Income
-$36.36M
EPS (Diluted)
-0.83
Price & Volume History
Loading chart…
Recent News
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 8:05 PM
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 11:00 AM
Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing
MT Newswires · Aug 19, 2026 8:22 PM
Do Avalo Therapeutics’ (AVTX) Widening Losses But Better EPS Reveal a Turning Point in Strategy?
Simply Wall St. · Aug 11, 2026 9:12 AM
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
GlobeNewswire · Aug 6, 2026 11:00 AM
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
GlobeNewswire · Jul 22, 2026 11:00 AM
Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares
MT Newswires · Jul 17, 2026 8:22 PM
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
GlobeNewswire · Jul 7, 2026 11:00 AM
Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index Additions - What's Changed
Simply Wall St. · Jun 30, 2026 1:07 AM
Sector Update: Healthcare Stocks Mixed Premarket Friday
MT Newswires · Jun 26, 2026 1:16 PM
Financial Overview - Income Statement
Quarterly
Dec 2025
See AVTX's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.